ELIZABETH G NABEL

CIK 1619929 · last filed 2026-05-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$2.53M

Companies

4

Total Filings

58

Lifetime Open-Market Net

-$10.46M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
MRNA	Director	19,317	$49.91	$964.1K	-$10.46M	15	2026-05-08
MDT	Director	19,584	$80.20	$1.57M	$0	18	2026-04-29
LYEL	Director	—	$13.50	—	$0	5	2025-05-19
Accolade, Inc. (ACCD) Delisted	Director	0	$7.02	$0	$0	20	2025-04-08

Recent Filings · Page 5 of 6

58 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2021-04-28	MDT	Tax (F)	−426	-$55.4K	EDGAR
2021-03-11	MRNA	Grant (A)	—	$0	EDGAR
2020-07-17	MRNA	Mixed	−14,344	-$5.55M	EDGAR
2020-06-04	MRNA	Sell (S)	−30,000	-$1.98M	EDGAR
2020-05-14	MRNA	Sell (S)	−30,000	-$1.98M	EDGAR
2020-04-30	MDT	Tax (F)	−393	-$39.0K	EDGAR
2020-04-30	MRNA	Grant (A)	—	$0	EDGAR
2020-04-29	MDT	Grant (A)	+1,737	$0	EDGAR
2019-06-28	MRNA	Grant (A)	—	$0	EDGAR
2019-06-12	MDT	Mixed	+1,573	-$38.1K	EDGAR

Showing 41–50 of 58

Prev Page 5 of 6 Next

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.